MDR and MRP Gene Families as Cellular Determinant Factors for Resistance to Clinical Anticancer Agents
- 1 January 2002
- book chapter
- Published by Springer Nature
- Vol. 112, 49-66
- https://doi.org/10.1007/978-1-4615-1173-1_3
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Regulation of expression of the multidrug resistance protein MRP1 by p53 in human prostate cancer cellsJournal of Clinical Investigation, 2000
- Expression of Multidrug Resistance Protein/GS-X Pump and γ-Glutamylcysteine Synthetase Genes Is Regulated by Oxidative StressJournal of Biological Chemistry, 1998
- Posttranscriptional Regulation ofMRP/GS-XPump and γ-Glutamylcysteine Synthetase Expression by 1-(4-Amino-2-methyl-5-pyrimidinyl) methyl-3- (2-chloroethyl)-3-nitrosourea and by Cycloheximide in Human Glioma CellsBiochemical and Biophysical Research Communications, 1997
- MDR1 gene expression in solid tumoursEuropean Journal Of Cancer, 1996
- Clinical trials of p-glycoprotein reversal in solid tumoursEuropean Journal Of Cancer, 1996
- What have we learnt thus far from mice with disrupted P-glycoprotein genes?European Journal Of Cancer, 1996
- MDR1/P-glycoprotein in haematological neoplasmsEuropean Journal Of Cancer, 1996
- Biology of the multidrug resistance-associated protein, MRPEuropean Journal Of Cancer, 1996
- Evidence that SP1 Modulates Transcriptional Activity of the Multidrug Resistance-Associated Protein GeneDNA and Cell Biology, 1996
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993